Mersana Therapeutics (MRSN) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

MRSN is expected to report earnings to fall 10.65% to -17 cents per share on November 05

Mersana Therapeutics MRSN Stock Earnings Reports

Q3'24

Est.

$-0.18

Q2'24

Missed

by $0.03

Q1'24

Beat

by $0.02

Q4'23

Beat

by $0.05

Q3'23

Beat

by $0.01

The last earnings report on August 13 showed earnings per share of -20 cents, missing the estimate of -17 cents. With 477.24K shares outstanding, the current market capitalization sits at 226.95M.

View a ticker or compare two or three

Compare

MRSN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For MRSN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of antibody drug conjugates to improve patient outcomes in multiple oncology indications

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

840 Memorial Drive

Phone

+1 617 498-0020

Employees

123

Web

https://www.mersana.com